Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -2.92% | 158.01 | 0.7% | $1348.71m | |
| PFE | Pfizer Inc. | -0.89% | 33.52 | 0.9% | $1215.71m | |
| BMY | Bristol-Myers Squibb Co. | -1.35% | 61.26 | 1.0% | $862.91m | |
| MRK | Merck & Co., Inc. | -2.73% | 72.58 | 0.7% | $818.60m | |
| ABBV | AbbVie, Inc. | 0.28% | 107.63 | 1.9% | $796.41m | |
| LLY | Eli Lilly & Co. | 0.43% | 204.69 | 1.1% | $749.41m | |
| AZN | AstraZeneca Plc | -1.08% | 48.38 | 1.2% | $499.92m | |
| GSK | GlaxoSmithKline Plc | -2.24% | 33.61 | 0.2% | $268.95m | |
| NVS | Novartis AG | -0.87% | 85.96 | 0.2% | $176.78m | |
| SNY | Sanofi | 0.20% | 45.89 | 0.2% | $170.59m | |
| VTRS | Viatris, Inc. | -1.33% | 14.85 | 0.0% | $143.27m | |
| VERU | Veru, Inc. | -3.22% | 13.82 | 0.0% | $113.90m | |
| CVAC | CureVac NV | 1.43% | 94.30 | 0.0% | $107.31m | |
| NVO | Novo Nordisk A/S | -1.47% | 71.28 | 0.1% | $90.64m | |
| VYNE | VYNE Therapeutics, Inc. | -5.45% | 7.46 | 0.0% | $88.66m |
Company Profile
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.